Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine in Persistent or Recurrent Non-Squamous Cell Carcinoma of the Cervix
NCT00039442Phase 2Completed
- Sponsor
- GOG Foundation
- Start
- Apr 2002
- Primary completion
- Dec 2005
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capecitabine in Cervical Cancer (CC), sponsored by GOG Foundation. Started Apr 2002; status: completed.
02
Drugs
capecitabine
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00039442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00039442.